It has been demonstrated that NGR-TNF induces apoptosis of tumor and endothelial cells in vivo [7,8], and that it can promote, through the involvement of the immune system, vessel normalization and an immune-supportive microenvironment, which ultimately results in reduced tumor growth [8]. The gene discussed is RTN4R; the disease is neoplasm.